“Effective and Rapid Osteoclast Inhibition by Denosumab, Is Reflected in Serum C Telopeptide (CTX), Across Different Tumor Types”. Journal of Analytical Oncology 2, no. 2 (April 3, 2013):  58–61. Accessed April 16, 2026. https://www.neoplasiaresearch.com/index.php/jao/article/view/67.